SUPERNUS PHARMACEUTICALS, INC. Quarterly Goodwill in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Supernus Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q4 2019 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Goodwill for the quarter ending September 30, 2024 was $117M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $117M $0 0% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $117M $0 0% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $117M $0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $117M $0 0% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $117M -$364K -0.31% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $117M +$1.61M +1.39% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $117M +$1.61M +1.39% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $117M -$497K -0.42% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $117M +$39.4M +50.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $115M +$37.5M +48% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $115M +$37.5M +48.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $118M +$39.6M +50.8% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $78M -$11.2M -12.5% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $78M -$10.1M -11.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $77.9M Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $77.9M +$77.9M Dec 31, 2020 10-K 2022-04-13
Q3 2020 $89.1M Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $88.1M Jun 30, 2020 10-Q 2020-08-17
Q4 2019 $0 Dec 31, 2019 10-K 2021-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.